Eligibility for thrombolytic therapy in acute myocardial infarction

Area of Science:

• Cardiology
• Emergency Medicine
• Pharmacology

Background:

• Acute myocardial infarction (AMI) is a leading cause of mortality.
• Thrombolytic therapy is a critical treatment for AMI.
• Assessing patient eligibility for thrombolysis is essential for effective treatment.

Purpose of the Study:

• To determine the proportion of patients admitted to a Coronary Care Unit (CCU) with chest pain who are suitable for thrombolytic therapy.
• To evaluate the impact of established criteria on thrombolytic therapy eligibility.
• To assess the prevalence of contraindications to thrombolysis in this patient cohort.

Main Methods:

• Prospective admission of 197 patients with chest pain to a CCU over six months.
• Confirmation of Acute Myocardial Infarction (AMI) in 131 patients.
• Assessment of eligibility for streptokinase thrombolytic therapy based on predefined criteria.

Main Results:

• 131 patients had confirmed AMI.
• 67 patients (51% of eligible) met criteria for thrombolytic therapy.
• 41 patients (31%) did not meet criteria, and 12 (9%) had contraindications.

Conclusions:

• Approximately half of AMI patients and one-third of chest pain patients admitted to CCU are suitable candidates for thrombolytic therapy.
• Current data suggest thrombolytic therapy is applicable to a significant patient group, not a small minority.
• Further research may optimize patient selection and expand thrombolytic therapy use in acute cardiac events.